Nominations et affiliations
Cardiologue interventionniste
Institut de cardiologie de l’Université d’Ottawa
Professeur adjoint
Université d’Ottawa
Le Dr Aun-Yeong Chong est cardiologue interventionniste à l’Institut de cardiologie de l’Université d’Ottawa (ICUO) et professeur adjoint au Département de médecine de l’Université d’Ottawa.
Parcours
Titulaire d’un baccalauréat ès sciences (médecine) et d’un doctorat en médecine et en chirurgie (MBBS) avec mention d’excellence de l’Université de New South Wales, à Sydney, en Australie, le Dr Chong a poursuivi sa formation au Royaume-Uni (R.-U.) où il a obtenu le titre de MRCP en 2001. Il détient en outre un doctorat en médecine que lui a remis l’Université de Birmingham en 2006 à l’issue de ses travaux de recherche à l’Unité d’hémostase, de thrombose et de biologie vasculaire du Birmingham City Hospital et du dépôt de sa thèse intitulée « Endothelial Function in Congestive Heart Failure ». Après une spécialisation en cardiologie dans la région des Midlands de l’Ouest, R.-U., il a suivi en 2008 et 2009 une formation spécialisée en cardiologie interventionnelle à l’ICUO.
Le Dr Chong, qui occupait depuis 2010 les fonctions de cardiologue interventionniste consultant au Royaume-Uni, est entré au service de l’ICUO en juin 2013 à titre de cardiologue.
Intérêts cliniques et de recherche
Dans le domaine clinique, le Dr Chong s’intéresse aux interventions coronariennes percutanées (ICP) dans le traitement des occlusions chroniques totales, à l’imagerie intravasculaire et à l’ICP transradiale. Ses travaux de recherche portent notamment sur l’ICP transradiale, la thrombose, la fonction endothéliale, la biologie des progéniteurs endothéliaux et la mobilisation des cellules souches dans l’infarctus du myocarde.
Publications
- Impact of access site selection and operator expertise on radiation exposure: a controlled prospective study. Lo TS, Ratib K, Chong AY , Bhatia G, Gunning M, Nolan J. Am Heart J. 2012 Oct; 164(4): 455-61
- Unprotected left main coronary artery stenting with zotarolimus (Endeavor) drug-eluting stents: a single center retrospective experience. Simard T, Hibbert B, Chong AY , Ruchin P, Le May M, Labinaz M, Froeschl M, So D, Glover C, Marquis JF, O’Brien E. Catheter Cardiovasc Interv. 2012 Aug 1; 80(2): E15-22
- Influence of atrial fibrillation on plasma von Willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure. Freestone B, Gustafsson F, Chong AY , Corell P, Kistorp C, Hilderbrandt P, Lip GY. Chest 2008 May; 133(5): 1203-8
- Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes. Kistorp C, Chong AY , Gustafsson F, Galatius S, Raymond I, Faber J, Lip GY, Hilderbrandt P. Eur J Heart Fail. 2008 Apr; 10(4): 380-7
- Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to von Willebrand factor and soluble E-selectin levels. Freestone B, Chong AY , Nuttall S, Lip GY . Thromb Res. 2008; 122(1): 85-90
- Soluble E-selectin, von Willebrand Factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation. Freestone B, Chong AY , Nuttall S, Blann AD, Lip GY. Chest 2007 Oct; 132(4): 1253-8
- Assessment of single versus twice daily dosing of ramipril by ambulatory blood pressure monitoring in patient similar to those included in the HOPE study. Goyal D, Chong AY , Watson RL, Prasad N, Watson RD. J Hum Hypertens 2007 Jul; 21(7): 525-30
- Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: The Frederiksberg heart failure study. Chong AY , Freestone B, Lim HS, Kistorp C, Gustafsson F, Hildebrandt P, Lip GY. Int J Cardiol. 2007 Jun 25; 119(1): 80-2
- Viewpoint: The prothrombotic state in congestive heart failure: A maladaptive inflammatory response? Chong AY , Lip GYH. Eur J Heart Fail. Feb 2007; 9(2): 124-8
- Endothelial function in congestive heart failure and its relationship to brain natriuretic peptide and clinical outcome. Chong AY , Freestone B, Patel J, Lim HS, Hughes E, Blann AD, Lip GYH. Am J Cardiol. 2006 Mar 1; 97(5): 671-5
- Circulating endothelial cells as an index of endothelial damage in congestive heart failure: relationship to plasma von Willebrand factor and soluble E-selectin levels. Chong AY , Freestone B, Blann AD, Lip GYH. Eur J Heart Fail. 2006 Mar; 8(2): 167-72
- The effects of direct current cardioversion for persistent atrial fibrillation on indices of endothelial damage/dysfunction. Freestone B, Chong AY , Blann AD, Lip GY . Thromb Res. 2006; 118(4): 479-85
- Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease. Freestone B, Lip GY, Chong AY , Nadar S, Lee KW, Blann AD. Thromb Haemost. 2005 Oct; 94(4): 702-6
- Effects of antiplatelet therapy and oral anticoagulation on indices of endothelial damage/dysfunction in patients with systolic heart failure in sinus rhythm. Chong AY , Chin BSP, Blann AD, Lip GYH. Thromb Res. 2005; 116(2): 181-3
- Angiogenic factors in atrial fibrillation: a possible role in thrombogenesis? Freestone B, Chong AY , Lim HS, Blann A, Lip GY. Ann Med. 2005; 37(5): 365-72
- The effect of multi-factorial intervention on plasma von Willebrand factor, soluble E-selectin and tissue factor in diabetes mellitus: implications for atherosclerotic vascular disease. Lim HS, Chong AY , Freestone B, Blann AD, Lip GY. Diabet Med. 2005 Mar; 22(3): 249-55
- Psychological interventions for depression in heart failure. Lane D, Chong A , Lip G. Cochrane Database Syst Rev. 2005 Jan 25; 1: CD003329
- Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention. Lim HS, Blann AD, Chong AY , Freestone B, Lip GY. Diabetes Care 2004 Dec; 27(12): 2918-24
- Endothelial dysfunction and damage in congestive heart failure: relationship of flow-mediated dilatation to circulating endothelial cells and plasma indices of endothelial damage. Chong AY , Blann AD, Patel J, Freestone B, Hughes E, Lip GYH. Circulation 2004 Sep 28; 110(13): 1794-8
- Angiopoietins/Tie-2 as mediators of angiogenesis: a role in congestive heart failure? Chong AY , Caine GJ, Lip GYH. Eur J Clin Invest 2004 Jan; 34(1): 9-13
- Plasma angiopoietins-1 and -2, and angiopoietin receptor tie-2 levels in congestive heart failure. Chong AY , Caine G, Freestone B, Blann AD, Lip GYH. J Am Coll Cardiol. 2004 Feb 4; 43(3): 423-8
- Heart failure in a multiethnic population in Kuala Lumpur, Malaysia. Chong AY , Rajaratnam R, Hussein N, Lip GYH. Eur J Heart Fail. 2003 Aug ; 5(4): 569-74